Production (Stage)
Drugs Made In America Acquisition Corp.
DMAA
$10.18
-$0.01-0.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | 1.25M | -279.90K | -- | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -1.49M | 31.60K | -- | ||
| Change in Net Operating Assets | -14.90K | 125.10K | -- | ||
| Cash from Operations | -251.20K | -123.20K | -- | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -231.15M | -- | -- | ||
| Cash from Investing | -231.15M | -- | -- | ||
| Total Debt Issued | -- | 1.39M | -- | ||
| Total Debt Repaid | -900.00K | -1.03M | -- | ||
| Issuance of Common Stock | 232.30M | 25.00K | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 3.20K | -260.40K | -- | ||
| Cash from Financing | 231.40M | 123.40K | -- | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -400.00 | 200.00 | -- | ||